A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-2592
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency ; volume:37 ; number:6 ; day:15 ; month:7 ; year:2017 ; pages:539-547 ; date:8.2017
Journal of clinical immunology ; 37, Heft 6 (15.7.2017), 539-547, 8.2017

Keyword
Biopharmazie
Pharmakodynamik
Pharmakokinetik

Creator
Krivan, Gergely
Contributor
Chernyshova, Ludmila
Kostyuchenko, Larysa
Lange, Andrzej
Nyul, Zoltan
Derfalvi, Beata
Musial, Jacek
Bellon, Anne
Kappler, Martin
Sadoun, Alain
Bernatowska, Ewa
SpringerLink (Online service)

DOI
10.1007/s10875-017-0416-4
URN
urn:nbn:de:1111-201710195323
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Krivan, Gergely
  • Chernyshova, Ludmila
  • Kostyuchenko, Larysa
  • Lange, Andrzej
  • Nyul, Zoltan
  • Derfalvi, Beata
  • Musial, Jacek
  • Bellon, Anne
  • Kappler, Martin
  • Sadoun, Alain
  • Bernatowska, Ewa
  • SpringerLink (Online service)

Other Objects (12)

Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma

Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency

Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia

Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia

Covariates of intravenous paracetamol pharmacokinetics in adults

Covariates of intravenous paracetamol pharmacokinetics in adults

Intravenous immunoglobulin therapy in COVID-19-related encephalopathy

Intravenous immunoglobulin therapy in COVID-19-related encephalopathy

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin

Treatment of multiple system atrophy using intravenous immunoglobulin

Treatment of multiple system atrophy using intravenous immunoglobulin

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy

Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin

Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin

Antifungal antibodies present in intravenous immunoglobulin derived from China

Antifungal antibodies present in intravenous immunoglobulin derived from China

Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin

Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin

Related objects